These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 10637278
1. A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. Lou Z, Jevremovic D, Billadeau DD, Leibson PJ. J Exp Med; 2000 Jan 17; 191(2):347-54. PubMed ID: 10637278 [Abstract] [Full Text] [Related]
2. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet JP, Abraham RT, Leibson PJ. Immunity; 1996 Dec 17; 5(6):629-38. PubMed ID: 8986721 [Abstract] [Full Text] [Related]
3. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells. Yusa S, Campbell KS. J Immunol; 2003 May 01; 170(9):4539-47. PubMed ID: 12707331 [Abstract] [Full Text] [Related]
4. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. Yusa S, Catina TL, Campbell KS. J Immunol; 2002 May 15; 168(10):5047-57. PubMed ID: 11994457 [Abstract] [Full Text] [Related]
5. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. Lowin-Kropf B, Kunz B, Beermann F, Held W. J Immunol; 2000 Aug 01; 165(3):1314-21. PubMed ID: 10903732 [Abstract] [Full Text] [Related]
6. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. Vyas YM, Mehta KM, Morgan M, Maniar H, Butros L, Jung S, Burkhardt JK, Dupont B. J Immunol; 2001 Oct 15; 167(8):4358-67. PubMed ID: 11591760 [Abstract] [Full Text] [Related]
7. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors. Bruhns P, Marchetti P, Fridman WH, Vivier E, Daëron M. J Immunol; 1999 Mar 15; 162(6):3168-75. PubMed ID: 10092767 [Abstract] [Full Text] [Related]
8. SHP-1/immunoreceptor tyrosine-based inhibition motif-independent inhibitory signalling through murine natural killer cell receptor Ly-49A in a transfected B-cell line. Motoda K, Takata M, Kiura K, Nakamura I, Harada M. Immunology; 2000 Jul 15; 100(3):370-7. PubMed ID: 10929060 [Abstract] [Full Text] [Related]
9. Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals. Vyas YM, Maniar H, Lyddane CE, Sadelain M, Dupont B. J Immunol; 2004 Aug 01; 173(3):1571-8. PubMed ID: 15265884 [Abstract] [Full Text] [Related]
10. Reconstitution of killer cell inhibitory receptor-mediated signal transduction machinery in a cell-free model system. Cho HI, Park CG, Kim J. Arch Biochem Biophys; 1999 Aug 15; 368(2):221-31. PubMed ID: 10441372 [Abstract] [Full Text] [Related]
11. LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase. Marti F, Xu CW, Selvakumar A, Brent R, Dupont B, King PD. Proc Natl Acad Sci U S A; 1998 Sep 29; 95(20):11810-5. PubMed ID: 9751747 [Abstract] [Full Text] [Related]
12. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2). Yusa S, Catina TL, Campbell KS. J Immunol; 2004 Jun 15; 172(12):7385-92. PubMed ID: 15187115 [Abstract] [Full Text] [Related]
13. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells. Mizuno K, Tagawa Y, Mitomo K, Arimura Y, Hatano N, Katagiri T, Ogimoto M, Yakura H. J Immunol; 2000 Aug 01; 165(3):1344-51. PubMed ID: 10903736 [Abstract] [Full Text] [Related]
14. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B. Wang LL, Blasioli J, Plas DR, Thomas ML, Yokoyama WM. J Immunol; 1999 Feb 01; 162(3):1318-23. PubMed ID: 9973385 [Abstract] [Full Text] [Related]
15. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Long EO, Barber DF, Burshtyn DN, Faure M, Peterson M, Rajagopalan S, Renard V, Sandusky M, Stebbins CC, Wagtmann N, Watzl C. Immunol Rev; 2001 Jun 01; 181():223-33. PubMed ID: 11513144 [Abstract] [Full Text] [Related]
16. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. Binstadt BA, Billadeau DD, Jevremović D, Williams BL, Fang N, Yi T, Koretzky GA, Abraham RT, Leibson PJ. J Biol Chem; 1998 Oct 16; 273(42):27518-23. PubMed ID: 9765283 [Abstract] [Full Text] [Related]
17. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, Watzl C. Blood; 2005 Jun 15; 105(12):4722-9. PubMed ID: 15713798 [Abstract] [Full Text] [Related]
18. Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells. Pisegna S, Zingoni A, Pirozzi G, Cinque B, Cifone MG, Morrone S, Piccoli M, Frati L, Palmieri G, Santoni A. J Immunol; 2002 Jul 01; 169(1):68-74. PubMed ID: 12077230 [Abstract] [Full Text] [Related]
19. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Billadeau DD, Upshaw JL, Schoon RA, Dick CJ, Leibson PJ. Nat Immunol; 2003 Jun 01; 4(6):557-64. PubMed ID: 12740575 [Abstract] [Full Text] [Related]
20. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant. Lin Chua H, Brahmi Z. Cell Immunol; 2002 Sep 01; 219(1):57-70. PubMed ID: 12473268 [Abstract] [Full Text] [Related] Page: [Next] [New Search]